Advanced search

Combine gene, variant, phenotype, region and year filters

Every result shows the extracted entities next to the sentences that support them; rows for the searched entities come first.

Transparent by designEvery result links extracted entities to its source sentence and publication identifier.
About your search

IDH1 and thyroid cancer are reported together in 2 articles.

Gene

IDH1

HGNC
HGNC:5382
41articles
41mentions
1variants with confirmed gene link
Most co-reported phenotypes (articles)
Reported variants (articles · ClinVar status)
216articles
216mentions
12co-reported genes shown
Most co-reported genes (articles)

Counts are literature co-mentions in SaudiVarKB, not clinical or causal assertions. Gene details: HGNC; variant status: ClinVar via dbSNP.

Publications

2 records shown · first 60

Meta-analysis of whole-genome gene expression datasets assessing the effects of IDH1 and IDH2 mutations in isogenic disease models.

PMID 34997121 | PMCID PMC8741954 | DOI 10.1038/s41598-021-04214-7 · Scientific reports · 2022 · 10 validated mentions
TypeEntitySource evidenceConfidenceExtractor
geneIDH1“Meta-analysis of whole-genome gene expression datasets assessing the effects of IDH1 and IDH2 mutations in isogenic disease models.”0.98hgnc_dict_v1
phenotypethyroid cancer“Mutations in isocitrate dehydrogenase 1 (IDH1) and IDH2 are oncogenic drivers to a variable extent in several tumors, including gliomas, acute myeloid leukemia (AML), cholangiocarcinoma, melanoma, and thyroid carcinoma.”0.93phenotype_alias_lexicon_v2
geneIDH2“Meta-analysis of whole-genome gene expression datasets assessing the effects of IDH1 and IDH2 mutations in isogenic disease models.”0.98hgnc_dict_v1
genePRSS23“Among differentially expressed genes (DEGs), serine protease 23 (PRSS23) was upregulated in four datasets, i.e., in human colon carcinoma cells, mouse heart tissue, mouse neural stem cells, and human glioma cells.”0.98hgnc_dict_v1

Analysis of ALK, IDH1, IDH2 and MMP8 somatic mutations in differentiated thyroid cancers.

PMID 34462665 | PMCID PMC8375036 | DOI 10.3892/mco.2021.2373 · Molecular and clinical oncology · 2021 · 9 validated mentions
TypeEntitySource evidenceConfidenceExtractor
geneIDH1“Analysis of ALK, IDH1, IDH2 and MMP8 somatic mutations in differentiated thyroid cancers.”0.98hgnc_dict_v1
phenotypethyroid cancer“Conversely, analyses of 117 aggressive thyroid cancers [84, poorly differentiated thyroid cancer (PDTC); 33, anaplastic thyroid cancer (ATC)] from the Memorial Sloan Kettering Cancer Center cohort revealed ALK mutations in 3% of ATCs and fusions in 3.6% of PDTCs.”0.98phenotype_alias_lexicon_v2
geneALK“Analysis of ALK, IDH1, IDH2 and MMP8 somatic mutations in differentiated thyroid cancers.”0.98hgnc_dict_v1
geneIDH2“Analysis of ALK, IDH1, IDH2 and MMP8 somatic mutations in differentiated thyroid cancers.”0.98hgnc_dict_v1